» Articles » PMID: 18264151

[Model for Estimation of Cardiovascular Risk in Norway]

Overview
Specialty General Medicine
Date 2008 Feb 12
PMID 18264151
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Guidelines for prevention of cardiovascular disease (CVD) include calculation of total risk. A new risk model based on updated Norwegian data is needed, as the European SCORE function overestimates the risk of fatal CVD in Norway. NORRISK for 10-year CVD mortality is presented. It includes gender, age and smoking and levels of systolic blood pressure and serumtotal cholesterol.

Material And Methods: NORRISK is based on national age- and sex specific mortality rates from Statistics Norway (1999-2003), mean levels of risk factors from Norwegian Health Surveys (2000-03) and relative risks from mortality follow-up of Norwegian Cardiovascular Screenings (1985-2002). The model is adjusted to the mortality level in the period 1999-2003 and is compared with the SCORE model.

Results: 10-year risk estimates calculated from NORRISK fall between SCORE high- and low-risk estimates and increase strongly with age. Very few persons below 50 years of age have a 10-year risk above 5% (European limit for high risk). More than half of men aged 60 years have estimated risks above this limit, while only 7% of 60-year-old women exceed the limit. Even if the risk limit is reduced to 1% for younger age groups, very few women below 50 years of age have risks above the limit.

Interpretation: NORRISK is more adapted to the current situation in Norway than the SCORE model and may be a useful and relevant tool in Norwegian clinical practice.

Citing Articles

Sex-Specific Survival Bias and Interaction Modeling in Coronary Artery Disease Risk Prediction.

Surakka I, Wolford B, Ritchie S, Hornsby W, Sutton N, Elvenstad Gabrielsen M Circ Genom Precis Med. 2022; 16(1):e003542.

PMID: 36580301 PMC: 10525909. DOI: 10.1161/CIRCGEN.121.003542.


Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015-2016.

Nilsen A, Hanssen T, Lappegard K, Eggen A, Lochen M, Selmer R Open Heart. 2021; 8(2).

PMID: 34462328 PMC: 8407203. DOI: 10.1136/openhrt-2021-001777.


Analgesic use in a Norwegian general population: change over time and high-risk use--The Tromsø Study.

Samuelsen P, Slordal L, Mathisen U, Eggen A BMC Pharmacol Toxicol. 2015; 16:16.

PMID: 26048167 PMC: 4456710. DOI: 10.1186/s40360-015-0016-y.


Physical activity and cardiovascular risk factors in a 40- to 42-year-old rural Norwegian population from 1975-2010: repeated cross-sectional surveys.

Solbraa A, Holme I, Graff-Iversen S, Resaland G, Aadland E, Anderssen S BMC Public Health. 2014; 14:569.

PMID: 24906521 PMC: 4064500. DOI: 10.1186/1471-2458-14-569.


Circulating microRNAs and aerobic fitness--the HUNT-Study.

Bye A, Rosjo H, Aspenes S, Condorelli G, Omland T, Wisloff U PLoS One. 2013; 8(2):e57496.

PMID: 23469005 PMC: 3585333. DOI: 10.1371/journal.pone.0057496.